Biological Stains Market Size was valued at USD 8.76 Billion in 2023. The Global Biological Stains industry is projected to grow from USD 9.89 Billion in 2024 to USD 12.76 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.65% during the forecast period (2024 - 2032).
Stains provide contrast to the object which makes it easy to examine. Stains are used to determine chemical, structural and physiological characteristics of the object. It has applications in molecular biology, biochemistry, microbiology as well as it is used for diagnostic purpose.
The rising number of healthcare and life sciences research activities, increasing commercial use of stains and increasing applications of stains in diagnostics are expected to drive the growth of the market. Moreover, a growing number of diseases such as tuberculosis are contributing to the growth of the market. According to the Centers for Disease Control and Prevention (CDC), In the year 2016, more than 10.4 million tuberculosis patients were present in the world, and 1.7 million deaths occurred due to tuberculosis in the year 2016.
The high cost of biological stains and issues related to contamination may hamper the growth of the market during the assessment period.
The biological stains market has been segmented on the basis of type, application, and end-user.
On the basis of type, the market has been classified as acid fuchsin, Congo red, crystal violet, eosin, methylene blue, iodine, safranin, and others. The eosin segment has been further divided into eosin Y, alcoholic eosin Y, eosin B, eosin- phloxine, and picro-eosin. The application segment has been further divided into histology, bacteriology, protein staining, gram staining, protein staining, DNA staining, and fluorescence microscopy.
The market, by end-user, has been segmented into diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biological stains market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European biological stains market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The biological stains market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The biological stains market in the Middle East & Africa has been segmented into the Middle East and Africa.
The Americas are likely to dominate the biological stains market owing to the rising prevalence of infectious diseases, increasing use of stains in food testing, and the presence of a well-established healthcare system. According to the Centers for Disease Control and Prevention, in the US, approximately 16.8 million patients visited physicians for the treatment of infectious diseases in the year 2015.
The European market is expected to be the second-largest biological stains market. The market growth in this region can be attributed to the increasing number of academic and research institutes in the region and with-it rising demand for biological reagents for research and academic purpose. Moreover, awareness about diagnostics and increasing expenditure on diagnostics are contributing to the growth of the market in this region.
Asia-Pacific is expected to be the fastest-growing biological stains during the forecast period owing to the increasing government support, rising investments in healthcare and the presence of well-established pharmaceutical market in the region. According to a report published by Australian Trade and Investment Commission, The Australian Government has spent more than USD 464.2 million on healthcare research and development in the year 2015.
The market in the Middle East & Africa is expected to account for the smallest share of the biological stains market due to an underdeveloped healthcare sector and lack of technical knowledge.
Some of the key players in the biological stains market are:
Biological Stains Market, by Type
Biological Stains Market, by Application
Biological Stains Market, by End-User
Biological Stains Market, by Region
Americas
Europe
Asia-Pacific
Middle East & Africa
Intended Audience
| Report Attribute/Metric | Details |
| Market Size | 12.76 Billion (By 2032) |
| CAGR | 11.65% (2024-2032) |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type,Application andEnd-User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Thermo Fisher Scientific Inc., Avantor, Becton, Dickinson and Company, Beckman Coulter, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, Water Corporation, bioMérieux SA |
| Key Market Opportunities | Increasing government support, rising investments in healthcare and the presence of well-established pharmaceutical market |
| Key Market Drivers | increasing applications of stains in diagnostics are expected to drive the growth of the market. |
Biological Stains Market Highlights:
Frequently Asked Questions (FAQ) :
Biological stains are chemicals used to highlight certain elements of objects being examined by microscopes.
Biological Stains Market is expected to exhibit a strong 11.65% CAGR over the forecast period from 2024 to 2032.
Growing pharmaceutical and biotechnology industry is the growing driver for the Biological Stains Market.
Americas hold the dominant share in the global Biological Stains Market.
Leading players in the Biological Stains Market include Merck, Avantor, and Becton Dickinson and Company, among others.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
